This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, E. R. Squibb Sons, Inc., National Institute of Health and Medical Research. Active years: 1997.
Company Filing History:
1 out of 5,383 
1 out of 1,624 
1 out of 1,853 
Years Active: 1997
Title: Isabelle Scheuer: Innovator in Antibody Research
Introduction
Isabelle Scheuer is a notable inventor based in Haguenau, France. She has made significant contributions to the field of antibody research, particularly in the development of antibodies specific for the retinoic acid receptor-gamma.
Latest Patents
Isabelle holds 1 patent for her invention titled "Antibodies specific for retinoic acid receptor-.gamma." This patent discloses methods for preparing antibodies that bind to specific isoforms of the human retinoic acid receptor-gamma (RAR-gamma). The invention includes several monoclonal antibodies that specifically bind to human RAR-gamma, while not binding to mouse RAR-gamma. Additionally, methods and kits are described that allow for the detection of the isotype of RAR-gamma expressed in test samples. These methods are valuable for determining the tissue-specific expression patterns of various RAR-gamma isoforms.
Career Highlights
Throughout her career, Isabelle has worked with prestigious institutions, including the University Louis Pasteur Strasbourg I and the National Institute of Health and Medical Research. Her work has significantly advanced the understanding of retinoic acid receptors and their isoforms.
Collaborations
Isabelle has collaborated with esteemed colleagues such as Cecille Rochette-Egly and Yves Lutz, contributing to the advancement of research in her field.
Conclusion
Isabelle Scheuer's innovative work in antibody research has made a lasting impact on the scientific community. Her contributions continue to influence the understanding of retinoic acid receptors and their applications in medical research.